Immucell
Executive Summary
Enters into new agreement with Bristol-Myers for R&D on "materials which may provide protection against certain infectious diseases in humans," the biotech firm says. Portland, Maine-based Immucell has been conducting related research for Bristol for two years. Further details of the agreement are not being disclosed.